Clofarabine blocks the proliferation of tumor cells by decreasing DNMT1 and inhibiting the methylation of TSGs, such as PTEN, antigen-presenting cells (APC), and RARβ2 [216]. The gene discussed is DNMT1; the disease is neoplasm.